Truscreen Group Ltd
NZX:TRU

Watchlist Manager
Truscreen Group Ltd Logo
Truscreen Group Ltd
NZX:TRU
Watchlist
Price: 0.019 NZD 5.56% Market Closed
Market Cap: NZ$14.2m

Relative Value

TRU doesn't have a meaningful market cap.

The Relative Value of one TRU stock under the Base Case scenario is 0.011 NZD. Compared to the current market price of 0.019 NZD, Truscreen Group Ltd is Overvalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TRU Relative Value
Base Case
0.011 NZD
Overvaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

TRU Competitors Multiples
Truscreen Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NZ
Truscreen Group Ltd
NZX:TRU
14.2m NZD 9.2 -5.8 -5 -5
US
Abbott Laboratories
NYSE:ABT
190.1B USD 4.3 29.1 16.5 22.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.4B USD 18 63.4 48.5 58.6
US
Stryker Corp
NYSE:SYK
140.5B USD 5.8 47.9 23.3 28.2
US
Boston Scientific Corp
NYSE:BSX
139.4B USD 7.2 49.9 29.2 39.8
IE
Medtronic PLC
NYSE:MDT
131.6B USD 3.8 27.6 15.5 22.4
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD 2.7 34.7 12.7 21.7
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR 2 22 12.6 17.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.1B USD 13 52.6 37.8 41.8
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD 8.1 34.7 24.7 27.1
US
Resmed Inc
NYSE:RMD
37.1B USD 7.1 25.9 18.6 20.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NZ
Truscreen Group Ltd
NZX:TRU
Average EV/EBITDA: 23.9
Negative Multiple: -5
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.5
9%
1.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
48.5
24%
2
US
Stryker Corp
NYSE:SYK
23.3
13%
1.8
US
Boston Scientific Corp
NYSE:BSX
29.2
22%
1.3
IE
Medtronic PLC
NYSE:MDT
15.5
8%
1.9
US
Becton Dickinson and Co
NYSE:BDX
12.7
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.6
11%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
37.8
14%
2.7
US
Edwards Lifesciences Corp
NYSE:EW
24.7
13%
1.9
US
Resmed Inc
NYSE:RMD
18.6
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
NZ
Truscreen Group Ltd
NZX:TRU
Average EV/EBIT: 30
Negative Multiple: -5
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.5
17%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
58.6
25%
2.3
US
Stryker Corp
NYSE:SYK
28.2
16%
1.8
US
Boston Scientific Corp
NYSE:BSX
39.8
32%
1.2
IE
Medtronic PLC
NYSE:MDT
22.4
17%
1.3
US
Becton Dickinson and Co
NYSE:BDX
21.7
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
17.7
15%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.8
15%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
27.1
14%
1.9
US
Resmed Inc
NYSE:RMD
20.6
12%
1.7